Navigation Links
SphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System

ProductsSphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System
Company AtCor Medical Pty Ltd.
Item SphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System
Features 
  • SphygmoCor Vx is a simple-to-use "doctors office" Pulse Wave Velocity system, with automated software analysis and database facilities
  • The pulse waveform recordings and ECG recordings are extensively evaluated to ensure consistent quality of the recordings
  • Only one operator is required to use the system
Description SphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System is an add-on package to the Px System.

The Vx system enables the measurement of the velocity of the pressure wave along a specific arterial segment. The velocity of the pressure wave along the artery is dependent upon the stiffness of the artery. This system is most commonly used to measure the aortic pulse wave velocity, by taking a reading at the carotid artery and the femoral artery. Aortic pulse wave velocity typically doubles between the ages of 30 and 60.

Pulse Wave Velocity

Arterial stiffness is a major cause of cardiovascular disease. Increases in arterial stiffness increase central systolic & pulse pressure, and demand on the left ventricle, and decrease the perfusion pressure through the coronary arteries, thereby increasing the risk of heart attacks, heart failure and stroke.

Pulse wave velocity is a well-established technique for obtaining a measure of arterial stiffness between two locations in the arterial tree. The velocity of the pulse wave along an artery is dependent on the stiffness of that artery.

Most commonly, pulse wave velocity is measured between the carotid and femoral peripheral artery sites in order to provide a measure of aortic stiffness. This aortic pulse wave velocity increases rapidly with age, typically doubling between the ages of 30 and 60.

The SphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System is sold as an add-on to Px System, and measures the velocity of the blood pressure waveform between any two superficial artery sites. It uses a single-lead ECG and then a tonometer to measure the pressure pulse waveform sequentially in the two peripheral artery sites (eg. carotid & femoral). When used in conjunction with the SphygmoCor Px System, the system provides a comprehensive assessment of the clinical significance of the arterial stiffness measured.

Info AtCor Medical Pty Ltd.
Customer Service: (630) 799-8217
Web site: http://www.atcormedical.com/

Related medicine products :

1. SphygmoCor Px Central Blood Pressure Assessment and Management System
2. SphygmoCor Mx Central Blood Pressure Monitoring System
3. SphygmoCor Px Pulse Wave Analysis System test
4. Innotrac Aio! Central
5. Endoalpha Centralized O.R. Control System
6. Centralized Holter Analysis
7. S/5 iCentral
8. Acuity LT Central Station
9. Mobile Acuity LT™ Central Station
10. Acuity® Central Station
11. Oxinet III Central Station Network
... CD-Chex Plus BC is an assayed control ... systems. CD-Chex Plus BC determines the accuracy ... in the process of immunophenotyping, including red ... subsets of leukocytes include: T lymphocytes, B ...
... tube for the collection, transport and retention ... flow cytometry. The preservative contained in Cyto-Chex ... blood cell cluster of differentiation (CD) markers ... collected in Cyto-Chex BCT are stable at ...
... a storage and transport solution ... blood cells in samples without ... sites. Samples treated with Cyto-Chex ... to seven days prior to ...
... CD-Chex CD34 is a stabilized ... which can be used as ... evaluating CD34 positive cells. It ... and ProCOUNT gating strategies. CD-Chex ...
Medicine Products:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Carlos ... problems. He has also continued to spiritually evolve, which is the purpose of everyone ... “ Our Spiritual Truths ” (published by Balboa Press) attempts to guide readers to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy has ... technology is so cutting edge, in fact, the U.S. Food and Drug Administration ... However, successful patient outcomes in certain clinical stem cell procedures have shown that ...
(Date:2/22/2017)... ... February 22, 2017 , ... South Bend’s Lunkerville, the award-winning TV ... feature Heroes On The Water (HOW), a non-profit organization dedicated to helping military veterans ... series host ‘Mike D’ traveling to Lake Denmark, New Jersey, to fish with war ...
(Date:2/22/2017)... Jacksonville, Fla. (PRWEB) , ... February 22, 2017 ... ... aneurysms is just as effective on smaller and sometimes harder to reach ones, ... findings were presented at the International Stroke Conference in Houston by Ricardo A. ...
(Date:2/22/2017)... Singapore, Singapore (PRWEB) , ... February 22, 2017 , ... ... high-end medical leads utilizing a simple online checklist. Over a period of just 24 ... with the assistance of an online checklist called T.A.D. , “The internet is not ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... NEW YORK , Feb. 22, 2017 /PRNewswire/ ... dominate medical implant demand, as aging demographic patterns ... heart-related conditions. Implants for sports- and exercise-related injuries, ... artery disease will lead sales gains. The future ... The study addresses the following questions and more: ...
(Date:2/23/2017)... Ill. , Feb. 23, 2017 Takeda ... subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) and Cognition ... PLC and Ctrl Group Limited, announced a collaboration to ... an Apple Watch wearable to monitor and assess cognitive ... Depression (MDD) is the leading cause of disability ...
(Date:2/23/2017)... 22, 2017 Mixed tocopherols market projected to grow ... market is projected to reach USD 5.27 billion by 2022, ... driven by factors such as health and wellness trends, for ... and regulations for sourcing, processing, packaging, and labeling of food ... markets such as the Asia-Pacific region ...
Breaking Medicine Technology: